DK2094116T3 - Fast eller vandig alkalisk fremstilling omfattende en kreatinkomponent, fremgangsmåde til fremstilling heraf og anvendelse heraf - Google Patents

Fast eller vandig alkalisk fremstilling omfattende en kreatinkomponent, fremgangsmåde til fremstilling heraf og anvendelse heraf

Info

Publication number
DK2094116T3
DK2094116T3 DK07819368.7T DK07819368T DK2094116T3 DK 2094116 T3 DK2094116 T3 DK 2094116T3 DK 07819368 T DK07819368 T DK 07819368T DK 2094116 T3 DK2094116 T3 DK 2094116T3
Authority
DK
Denmark
Prior art keywords
preparation
solid
aqueous alkaline
creatine
component
Prior art date
Application number
DK07819368.7T
Other languages
English (en)
Inventor
Thomas Gastner
Original Assignee
Alzchem Trostberg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38980980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2094116(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alzchem Trostberg Gmbh filed Critical Alzchem Trostberg Gmbh
Application granted granted Critical
Publication of DK2094116T3 publication Critical patent/DK2094116T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK07819368.7T 2006-10-28 2007-10-26 Fast eller vandig alkalisk fremstilling omfattende en kreatinkomponent, fremgangsmåde til fremstilling heraf og anvendelse heraf DK2094116T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006050931A DE102006050931A1 (de) 2006-10-28 2006-10-28 Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
PCT/EP2007/009324 WO2008052712A1 (de) 2006-10-28 2007-10-26 Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
DK2094116T3 true DK2094116T3 (da) 2010-09-06

Family

ID=38980980

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07819368.7T DK2094116T3 (da) 2006-10-28 2007-10-26 Fast eller vandig alkalisk fremstilling omfattende en kreatinkomponent, fremgangsmåde til fremstilling heraf og anvendelse heraf

Country Status (11)

Country Link
US (1) US20100056633A1 (da)
EP (1) EP2094116B1 (da)
JP (1) JP5590889B2 (da)
AT (1) ATE468030T1 (da)
CA (1) CA2667667C (da)
DE (2) DE102006050931A1 (da)
DK (1) DK2094116T3 (da)
ES (1) ES2341910T3 (da)
PL (1) PL2094116T3 (da)
SI (1) SI2094116T1 (da)
WO (1) WO2008052712A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
DE102007062288A1 (de) 2007-12-21 2009-06-25 Alzchem Trostberg Gmbh Kreatin-Zubereitung und Verfahren zu deren Herstellung
CN103830229A (zh) 2008-12-30 2014-06-04 希尔氏宠物营养品公司 硫辛酸在治疗或预防陪伴动物的退行性关节病症、骨关节炎、软骨损伤，以及相关障碍中的应用
EP2416770B1 (en) * 2009-04-06 2016-10-26 Crearene Ltd. Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
CA2914514C (en) 2013-06-12 2021-03-30 Anabio Technologies Limited A process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell.
JP6991445B2 (ja) 2016-09-06 2022-02-03 地方独立行政法人青森県産業技術センター アルギニンを豊富に含有する多糖

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322407A (en) * 1978-12-11 1982-03-30 Vitapharm Pharmaceutical Pty. Ltd. Electrolyte drink
US5151274A (en) * 1990-08-06 1992-09-29 The Procter & Gamble Company Calcium and trace mineral supplements
US5318784A (en) * 1992-09-09 1994-06-07 Amurol Products Company Pourable chewing gum and confection composition
US5908864A (en) * 1998-05-28 1999-06-01 Dymatize Enterprises Creatine gel
DE19830768A1 (de) * 1998-07-09 2000-01-13 Sueddeutsche Kalkstickstoff Kreatin-enthaltende Formulierung und Verfahren zu deren Herstellung
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6114379A (en) * 1999-07-07 2000-09-05 Albion Laboratories, Inc. Bioavailable chelates of creatine and essential metals
WO2001089476A1 (en) * 2000-05-19 2001-11-29 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US6399661B1 (en) * 2000-06-26 2002-06-04 Jeffrey M. Golini Oral creatine supplement and method for making same
DE60215312T2 (de) * 2001-03-02 2007-04-19 The Howard Foundation, Cambridge Zusammensetzung enthaltend kreatin und kreatinin
DE10215007A1 (de) * 2002-04-05 2003-10-16 Degussa Bioactives Deutschland Verwendung von Kreatinpyruvat zur Steigerung der Ausdauer bei hochintensiven körperlichen Intervallbelastungen
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
US7238373B2 (en) * 2003-04-04 2007-07-03 Nutritox Llc Nutritional supplement
GB0323240D0 (en) * 2003-10-03 2003-11-05 Golini Jeffrey M Creatine composition and use
DE502005002355D1 (de) * 2004-06-09 2008-02-07 Evonik Degussa Gmbh Guanidinoessigsäure als futtermittelzusatz
US20080003208A1 (en) * 2006-05-11 2008-01-03 Avicena Froup, Inc. Creatine-ligand compounds and methods of use thereof

Also Published As

Publication number Publication date
JP5590889B2 (ja) 2014-09-17
EP2094116B1 (de) 2010-05-19
EP2094116A1 (de) 2009-09-02
PL2094116T3 (pl) 2010-10-29
WO2008052712A1 (de) 2008-05-08
DE102006050931A1 (de) 2008-04-30
US20100056633A1 (en) 2010-03-04
ATE468030T1 (de) 2010-06-15
JP2010508249A (ja) 2010-03-18
DE502007003888D1 (de) 2010-07-01
CA2667667C (en) 2014-09-09
CA2667667A1 (en) 2008-05-08
ES2341910T3 (es) 2010-06-29
SI2094116T1 (sl) 2010-09-30

Similar Documents

Publication Publication Date Title
DK2094116T3 (da) Fast eller vandig alkalisk fremstilling omfattende en kreatinkomponent, fremgangsmåde til fremstilling heraf og anvendelse heraf
AR047949A1 (es) Preparacion farmaceutica que comprende un anticuerpo contra el receptor de factor de crecimiento endotelial
WO2018136224A3 (en) POSITIONING BASED ON LOCATION POSITIONING PROTOCOL FOR USER EQUIPMENT IN SLEEP MODE
EA200901365A1 (ru) Стабилизированная фармацевтическая композиция, содержащая прегабалин
NO20064997L (no) Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning
DK1776010T3 (da) Fremgangsmåde til fremstilling af vandige aktivstofsammensætninger af aktivstoffer, som er tungt oplöselige i vand
BRPI0609278B8 (pt) método para preparar uma composição farmacêutica e composição farmacêutica
IL208183A0 (en) Argatroban formulation
GEP20105031B (en) Stable emulsion composition
WO2006003371A3 (en) Herbicidal suspension concentrate formulation
CL2011000671A1 (es) Procedimiento para formar una composicion acuosa de proteina de tejido muscular animal que contiene proteinas sarcoplasmicas y miofibrilares que comprende: a) triturar proteina muscular animal, b) mezclar dicha proteina con una composicion de una base de uso permitido en alimentos formado una solucion acuosa basica de ph 11,5-12,0.c) mezclar la solucion basica con una composicion acida formando una composicion acuosa de ph 4,7-11,0,d) triturar.
NZ593787A (en) Lyophilised dabigatran
EA201171399A1 (ru) Способ и композиция для улучшения всасывания лекарственных средств
DK1740213T3 (da) Væskeformulering til væksthormoner
WO2009090439A3 (en) Method for stabilization of s-nitrosoglutathione and composition prepared by the same
ATE511837T1 (de) Wässrige arzneimittelformulierung von 4-ä((4- carboxybutyl)-ä2-ä(4-phenethyl-benzyl)oxyü- phenethylüamino)methylübenzoesäure
DK1976538T3 (da) Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
CL2008001280A1 (es) Composicion farmaceutica que comprende una sal de aminoacido n-halogenado; procedimiento de preparacion; y su uso como antimicrobiano.
NO20063233L (no) Fremgangsmate for redusering av alkoholindusert doseuttomming for opioide orale doseringsformer med langvarig frigivning
GEP20094657B (en) New strontium salts of sulphonic acids, preparation method and pharmaceutical compositions containing them
TR201005241A1 (tr) Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
WO2007138462A3 (en) Aqueous oral formulations of risperidone
AR077831A1 (es) Metodo para preparar una lechada flavonoide
WO2010095978A3 (ru) Способ получения препарата проинсулина для перорального применения